Login
← Go Back
Gufic Biosciences
GUFICBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Jayesh P Choksi · MD: Jayesh P Choksi · Listing date: Oct. 20, 2004 · Employees: 1247 · Mumbai · http://gufic.com
Stock Price vs Company Growth
1d
0.6%
1w
9.5%
1m
22.6%
3m
30.6%
6m
45.7%
1y
74.8%
5y
45.9%
10y
37.9%
all
23.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 463 0.6%
335
480
Company Overview
Sales
814 Cr
Growth: 11.8%
Profit after Tax
86.4 Cr
Growth: 0.3%
Small Cap
4,642 Cr
P/E: 52.8x
Industry P/E: 41.6x
Fundamentals
Sales (Cr) ₹ 814
Growth 11.8%
EBITDA 17.9%
P/S 5.7x
Dividend 0.0%
P/E 52.8x
Book Value ₹ 1
PEG Ratio 4.6x
ROE 868.5%
P/B N/A
Shareholding Pattern
Institutions
Sbi Healthcare Opportunities Fund
2.61 %
Promoters
Mr. Jayesh P. Choksi
25.95 %
Zircon Teconica Private Limited (Formely Known As Zircon Finance & Leasing Private Limited)
21.17 %
Gufic Private Limited
10.51 %
Mr. Pranav J. Choksi
7.5 %
Others
Vipula Jayesh Choksi
10.35 %
Jagdish N Master
1.65 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
The company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.Products of the companyPharmaceuticalHerbalAPI / Bulk DrugsPersonal careInternationalHistory and milestonePast InitiativesFirst Indian to produce Doxycycline Inj.First Indian company to make Liquid Oxytetracycline Inj.
Belongs to (4 Indices)
Investors (46)
icici.pr...
sbi.acti...
iepf
Followers (7)
indrajee...
nihal
mrinmoy4